Last reviewed · How we verify
NCT06724861
Sensory Rehabilitation in Chemo Induced Peripheral Neuropathy
NA trial testing Explicit Sensory Retraining for the lower extremities in CIPN - Chemotherapy-Induced Peripheral Neuropathy in 27 participants. Not yet recruiting.
11 December 2024
Quick facts
| Lead sponsor | Assaf-Harofeh Medical Center |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 27 |
| Start date | 11 December 2024 |
| Primary completion | 11 December 2024 |
| Estimated completion | 11 December 2026 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- Explicit Sensory Retraining for the lower extremities
- no treatment — full drug profile →
Conditions studied
- CIPN - Chemotherapy-Induced Peripheral Neuropathy — all drugs for CIPN - Chemotherapy-Induced Peripheral Neuropathy →
- Age Over 18 — all drugs for Age Over 18 →
- Chemotherapy-induced Peripheral Neuropathy — all drugs for Chemotherapy-induced Peripheral Neuropathy →
Sponsor
Assaf-Harofeh Medical Center
Who can join
18 and older, any sex, with CIPN - Chemotherapy-Induced Peripheral Neuropathy or Age Over 18. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a cross-over RCT evaluating the effectiveness of 3 sessions a week apart of explicit sensory retraining to the lower extremities in individuals with CIPN versus usual care. The primary outcome measures are TNAS for subjective symptoms, VAS for pain and TUG for mobility. Additional outcome measures are FABS for balance, sensory assessments - monofilaments for touch threshold, LEPT for proprioception, a home exercise log and a satisfaction questionnaire.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06724861
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for CIPN - Chemotherapy-Induced Peripheral Neuropathy
Currently open trials in the same condition.
- NCT06914557 — Scrambler Therapy With Duloxetine-based Usual Care vs Duloxetine-based Usual Care for Chemotherapy-induced Peripheral Ne · Phase 2 · recruiting
- NCT05121558 — The Effect of Yoga on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy) · NA · active not recruiting
- NCT04917796 — The Effect of Electroacupuncture on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy) · NA · active not recruiting
- NCT05928429 — Effects of Cryotherapy on Taxane-Induced Neuropathy in Patients With Breast Cancer · NA · recruiting
Other Assaf-Harofeh Medical Center trials
Trials by the same sponsor.
- NCT07334639 — Metabolic Changes Associated With Weight Gain After Treatment of Achalasia · not yet recruiting
- NCT07276334 — Same Day Discharge Vs. Hospitalization for Operative Fixation of Distal Radius Fractures · NA · enrolling by invitation
- NCT07231900 — Sodium Bicarbonate in Intra-dialytic Hypertension in Chronic Hemodialysis Patients · Phase 2, PHASE3 · not yet recruiting
- NCT07252180 — Comparing Two Different Methods of Ablation of Inlet Patches (APC vs RFA) · NA · active not recruiting
- NCT04664790 — Hyperbaric Oxygen Therapy Compared to Cognitive Training in FASD · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06724861 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assaf-Harofeh Medical Center
- Last refreshed: 9 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06724861.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing